XML 85 R45.htm IDEA: XBRL DOCUMENT v3.25.0.1

Segment and Geographic Data (Tables)

12 Months Ended

Dec. 31, 2024

Segment Reporting [Abstract]

Reconciliation of Operating Profit (Loss) from Segments to Consolidated

Segment Results			2024						2023						2022
MedSurg and Neurotechnology			$	13,518					$	12,163					$	10,893
Orthopaedics			$	9,077					8,335						7,556
Net sales			$	22,595					$	20,498					$	18,449
MedSurg and Neurotechnology			$	5,320					$	4,876					$	4,637
Orthopaedics			$	2,400					2,254						1,920
Cost of sales			$	7,720					$	7,130					$	6,557
MedSurg and Neurotechnology			$	784					$	702					$	682
Orthopaedics			$	540					508						477
Segment research, development and engineering expenses			$	1,324					$	1,210					$	1,159
MedSurg and Neurotechnology			$	3,203					$	2,934					$	2,564
Orthopaedics			$	3,111					2,922						2,608
Segment selling, general and administrative expenses			$	6,314					$	5,856					$	5,172
MedSurg and Neurotechnology			$	208					$	181					$	178
Orthopaedics			433						386						350
Segment depreciation and amortization			$	641					$	567					$	528
Corporate and Other			162						139						123
Amortization of intangible assets			623						635						627
Total depreciation and amortization			$	1,426					$	1,341					$	1,278
MedSurg and Neurotechnology			$	4,004					$	3,470					$	2,831
Orthopaedics			2,591						2,265						2,202
Segment operating income			$	6,595					$	5,735					$	5,033
Items not allocated to segments:
Corporate and Other			$	(880)					$	(780)					$	(649)
Inventory stepped up to fair value			(46)						—						—
Acquisition and integration-related charges			(108)						(20)						(138)
Amortization of intangible assets			(623)						(635)						(627)
Structural optimization and other special charges			(138)						(170)						(295)
Goodwill and other impairments			(977)						(36)						(270)
Medical device regulation			(58)						(96)						(140)
Recall-related matters			(40)						(18)						15
Regulatory and legal matters			(36)						(92)						(76)
Consolidated operating income			$	3,689					$	3,888					$	2,841

Sales and Other Financial Information by Business Segment

Segment Assets and Capital Spending
Assets:			2024						2023
MedSurg and Neurotechnology			$	23,115					$	20,804
Orthopaedics			18,507						18,023
Total segment assets			$	41,622					$	38,827
Corporate and Other			1,349						1,085
Total assets			$	42,971					$	39,912
Purchases of property, plant and equipment:			2024						2023						2022
Orthopaedics			$	230					$	179					$	173
MedSurg and Neurotechnology			276						183						175
Total segment purchases of property, plant and equipment			$	506					$	362					$	348
Corporate and Other			249						213						240
Total purchases of property, plant and equipment			$	755					$	575					$	588

Geographic Information on Net Sales and Long-Lived Assets

Geographic Information
			Net Sales																		Net Property, Plant and Equipment
			2024						2023						2022						2024						2023
United States			$	16,943					$	15,257					$	13,638					$	1,997					$	1,874
Europe, Middle East, Africa			2,897						2,618						2,348						1,260						1,151
Asia Pacific			2,020						1,946						1,885						75						77
Other countries			735						677						578						116						113
Total			$	22,595					$	20,498					$	18,449					$	3,448					$	3,215

X

- Definition

Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-31

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the names of foreign countries in which material long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets are located, and amount of such long-lived assets located in that country or foreign geographic area.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

+ Details

Name:	us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration